Baikowski SA
PAR:ALBKK
US |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
|
US |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Mastercard Inc
NYSE:MA
|
Technology
|
|
US |
Abbvie Inc
NYSE:ABBV
|
Biotechnology
|
|
US |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
|
US |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
|
US |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
|
US |
Visa Inc
NYSE:V
|
Technology
|
|
CN |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
|
US |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
|
US |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
|
US |
Coca-Cola Co
NYSE:KO
|
Beverages
|
|
US |
Realty Income Corp
NYSE:O
|
Real Estate
|
|
US |
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
|
US |
Walt Disney Co
NYSE:DIS
|
Media
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
This note will be permanently deleted.
Baikowski SA
Capital Expenditures
Baikowski SA
Capital Expenditures Peer Comparison
Competitive Capital Expenditures Analysis
Latest Figures & CAGR of Competitors
Company | Capital Expenditures | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Baikowski SA
PAR:ALBKK
|
Capital Expenditures
-€3.2m
|
CAGR 3-Years
-23%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Robertet SA
PAR:RBT
|
Capital Expenditures
-€17.3m
|
CAGR 3-Years
-5%
|
CAGR 5-Years
0%
|
CAGR 10-Years
-2%
|
|
Fermentalg SA
PAR:FALG
|
Capital Expenditures
-€470k
|
CAGR 3-Years
41%
|
CAGR 5-Years
11%
|
CAGR 10-Years
N/A
|
|
Sergeferrari Group SA
PAR:SEFER
|
Capital Expenditures
-€16.4m
|
CAGR 3-Years
-27%
|
CAGR 5-Years
-16%
|
CAGR 10-Years
N/A
|
|
Orapi SA
PAR:ORAP
|
Capital Expenditures
-€6.2m
|
CAGR 3-Years
-2%
|
CAGR 5-Years
4%
|
CAGR 10-Years
1%
|
|
G
|
Groupe Berkem SA
PAR:ALKEM
|
Capital Expenditures
-€12m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Baikowski SA's Capital Expenditures?
Capital Expenditures
-3.2m
EUR
Based on the financial report for Dec 31, 2023, Baikowski SA's Capital Expenditures amounts to -3.2m EUR.
What is Baikowski SA's Capital Expenditures growth rate?
Capital Expenditures CAGR 3Y
-23%
Over the last year, the Capital Expenditures growth was -21%. The average annual Capital Expenditures growth rates for Baikowski SA have been -23% over the past three years .